EFFECTIVENESS AND SAFETY OF BLONANSERIN FOR IMPROVING SOCIAL AND COGNITIVE FUNCTIONS IN PATIENTS WITH FIRST-EPISODE SCHIZOPHRENIA

Authors
Category Primary study
Conference35th CINP World Congress Neuropsychopharmacology
Year 2025
This article has no abstract
Epistemonikos ID: b2fecf138305407349ad65fd01fd95dd53665317
First added on: Nov 07, 2025